These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 19536710

  • 1. [Angiogenic factors and their role in pathogenesis and prediction of preeclampsia].
    Stepan H, Jank A.
    Z Geburtshilfe Neonatol; 2009 Jun; 213(3):101-5. PubMed ID: 19536710
    [Abstract] [Full Text] [Related]

  • 2. Angiogenic factors and preeclampsia.
    Steinberg G, Khankin EV, Karumanchi SA.
    Thromb Res; 2009 Jun; 123 Suppl 2():S93-9. PubMed ID: 19217486
    [Abstract] [Full Text] [Related]

  • 3. Preeclampsia: the role of angiogenic factors in its pathogenesis.
    Wang A, Rana S, Karumanchi SA.
    Physiology (Bethesda); 2009 Jun; 24():147-58. PubMed ID: 19509125
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion.
    Stepan H, Unversucht A, Wessel N, Faber R.
    Hypertension; 2007 Apr; 49(4):818-24. PubMed ID: 17261644
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia.
    Moore AG, Young H, Keller JM, Ojo LR, Yan J, Simas TA, Maynard SE.
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2651-7. PubMed ID: 22861812
    [Abstract] [Full Text] [Related]

  • 7. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia.
    Silasi M, Cohen B, Karumanchi SA, Rana S.
    Obstet Gynecol Clin North Am; 2010 Jun; 37(2):239-53. PubMed ID: 20685551
    [Abstract] [Full Text] [Related]

  • 8. Pre-eclampsia: clinical manifestations and molecular mechanisms.
    Baumwell S, Karumanchi SA.
    Nephron Clin Pract; 2007 Jun; 106(2):c72-81. PubMed ID: 17570933
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. New markers in preeclampsia.
    Hertig A, Liere P.
    Clin Chim Acta; 2010 Nov 11; 411(21-22):1591-5. PubMed ID: 20659441
    [Abstract] [Full Text] [Related]

  • 11. Angiogenic factors and pre-eclampsia: an early marker is needed.
    Stepan H.
    Clin Sci (Lond); 2009 Feb 11; 116(3):231-2. PubMed ID: 19032146
    [Abstract] [Full Text] [Related]

  • 12. Angiogenic factors and preeclampsia.
    Tjoa ML, Levine RJ, Karumanchi SA.
    Front Biosci; 2007 Jan 01; 12():2395-402. PubMed ID: 17127249
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Angiogenic factors in the pathogenesis of preeclampsia.
    Yuan HT, Haig D, Ananth Karumanchi S.
    Curr Top Dev Biol; 2005 Jan 01; 71():297-312. PubMed ID: 16344109
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia.
    Kim YN, Lee DS, Jeong DH, Sung MS, Kim KT.
    Prenat Diagn; 2009 May 01; 29(5):464-70. PubMed ID: 19242927
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Review: Biochemical markers to predict preeclampsia.
    Anderson UD, Olsson MG, Kristensen KH, Åkerström B, Hansson SR.
    Placenta; 2012 Feb 01; 33 Suppl():S42-7. PubMed ID: 22197626
    [Abstract] [Full Text] [Related]

  • 20. Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction.
    Stepan H, Krämer T, Faber R.
    J Clin Endocrinol Metab; 2007 Jul 01; 92(7):2831-4. PubMed ID: 17426082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.